Crossmark Global Holdings’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $468K | Sell |
3,223
-98
| -3% | -$12.2K | 0.01% | 895 |
|
|
2026
Q1 | $352K | Sell |
3,321
-30
| -0.9% | -$3.41K | 0.01% | 956 |
|
|
2025
Q4 | $356K | Sell |
3,351
-51
| -1% | -$5.15K | 0.01% | 958 |
|
|
2025
Q3 | $319K | Sell |
3,402
-101
| -3% | -$9.39K | ﹤0.01% | 1072 |
|
|
2025
Q2 | $304K | Sell |
3,503
-7
| -0.2% | -$586 | ﹤0.01% | 1093 |
|
|
2025
Q1 | $271K | Buy |
3,510
+8
| +0.2% | +$734 | ﹤0.01% | 1135 |
|
|
2024
Q4 | $338K | Hold |
3,502
| – | – | 0.01% | 998 |
|
|
2024
Q3 | $332K | Buy |
3,502
+90
| +3% | +$7.86K | 0.01% | 1039 |
|
|
2024
Q2 | $285K | Sell |
3,412
-257
| -7% | -$21.4K | 0.01% | 1087 |
|
|
2024
Q1 | $315K | Buy |
3,669
+41
| +1% | +$3.34K | 0.01% | 1073 |
|
|
2023
Q4 | $300K | Sell |
3,628
-302
| -8% | -$22.2K | 0.01% | 1067 |
|
|
2023
Q3 | $280K | Sell |
3,930
-16
| -0.4% | -$1.21K | 0.01% | 1048 |
|
|
2023
Q2 | $297K | Sell |
3,946
-252
| -6% | -$16.9K | 0.01% | 1078 |
|
|
2023
Q1 | $265K | Buy |
4,198
+66
| +2% | +$3.87K | 0.01% | 1094 |
|
|
2022
Q4 | $225K | Sell |
4,132
-313
| -7% | -$18.6K | 0.01% | 1140 |
|
|
2022
Q3 | $254K | Sell |
4,445
-86
| -2% | -$4.77K | 0.01% | 1070 |
|
|
2022
Q2 | $211K | Sell |
4,531
-20
| -0.4% | -$1.05K | 0.01% | 1189 |
|
|
2022
Q1 | $260K | Buy |
4,551
+270
| +6% | +$13.9K | 0.01% | 1197 |
|
|
2021
Q4 | $226K | Buy |
+4,281
| New | +$229K | ﹤0.01% | 1290 |
|
|
2021
Q3 | – | Sell |
-3,911
| Closed | -$230K | – | 1401 |
|
|
2021
Q2 | $230K | Sell |
3,911
-733
| -16% | -$45.3K | 0.01% | 1311 |
|
|
2021
Q1 | $302K | Sell |
4,644
-260
| -5% | -$16K | 0.01% | 1166 |
|
|
2020
Q4 | $269K | Sell |
4,904
-2,460
| -33% | -$126K | 0.01% | 1151 |
|
|
2020
Q3 | $325K | Hold |
7,364
| – | – | 0.01% | 971 |
|
|
2020
Q2 | $311K | Buy |
7,364
+440
| +6% | +$16.9K | 0.01% | 984 |
|
|
2020
Q1 | $275K | Buy |
6,924
+30
| +0.4% | +$1.27K | 0.01% | 898 |
|
|
2019
Q4 | $307K | Sell |
6,894
-3,530
| -34% | -$136K | 0.01% | 1108 |
|
|
2019
Q3 | $357K | Sell |
10,424
-230
| -2% | -$7.96K | 0.01% | 953 |
|
|
2019
Q2 | $401K | Buy |
10,654
+451
| +4% | +$15.4K | 0.01% | 933 |
|
|
2019
Q1 | $312K | Sell |
10,203
-42
| -0.4% | -$1.28K | 0.01% | 1094 |
|
|
2018
Q4 | $284K | Buy |
+10,245
| New | +$281K | 0.01% | 1109 |
|
Other funds holding ACA
NAMI
RA
Crossmark Global Holdings's ACA Position: Q2 2026 in Review
Crossmark Global Holdings reduced its Arcosa (ACA) stake by 3% in Q2 2026, selling an estimated $12.2K and leaving 3,223 shares worth $468K. The position accounts for 0.01% of the portfolio, ranked #895.
Crossmark Global Holdings first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. 428 funds tracked by Wall St. Rank hold ACA as of Q2 2026.
- Crossmark Global Holdings held 3,223 shares of Arcosa worth $468K as of Q2 2026.
- Crossmark Global Holdings sold 98 Arcosa shares in Q2 2026, an estimated $12.2K.
- Arcosa made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #895 holding.
- Crossmark Global Holdings first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
- 428 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.